| Overview |
| bsm-90140r-50µL |
| SMAD5 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human Smad5 |
| 220-284/465 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 4090 |
| Q99717 |
| SMAD Family Member 5; JV5-1; MADH5; Mothers Against Decapentaplegic Homolog; DWFC; MAD Mothers Against Decapentaplegic Homolog 5 (Drosophila); Mothers Against Decapentaplegic Drosophila Homolog Of 5; SMAD Mothers Against DPP Homolog 5 (Drosophila) 2; MAD Mothers Against Decapentaplegic Homolog 5; SMAD Mothers Against DPP Homolog 5; SMA- And MAD-Related Protein 5; Mothers Against DPP Homolog 5; MAD Homolog 5; SMAD 5; HSmad5; Smad5; Dwfc |
| Cell Line: HeLa Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |